Literature DB >> 8200131

Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man.

O Thraenhart1, E Kreuzfelder, M Hillebrandt, I Marcus, K Ramakrishnan, Z F Fu, B Dietzschold.   

Abstract

To determine the duration of anti-rabies immunity, peripheral blood of 18 vaccinees was obtained between 2 and 14 years after immunization. Peripheral blood mononuclear cells (PBMC) and serum were tested for the presence of either rabies virus-specific antibodies or rabies antigen-specific proliferation. Neutralizing immunoglobulin class G anti-rabies virus antibodies could be detected in sera of all vaccinees, but not in 18 age- and sex-matched controls. Rabies antigen-induced proliferation of PBMCs from vaccinees was significantly higher than that of controls. The anti-rabies T and B cell response showed no time-dependent pattern. These results suggest the induction of a long-term immunity after rabies immunization according to pre- and post-exposure schedules with inactivated cell culture vaccines against rabies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200131     DOI: 10.1006/clin.1994.1088

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  12 in total

Review 1.  [Rabies: epidemiology, pre- and postexposure immunization].

Authors:  Herwig Kollaritsch; Wolfgang Maurer
Journal:  Wien Klin Wochenschr       Date:  2006-06       Impact factor: 1.704

2.  Detection of cellular immunity to rabies antigens in human vaccinees.

Authors:  Susan M Moore; Melinda J Wilkerson; Rolan D Davis; Carol R Wyatt; Deborah J Briggs
Journal:  J Clin Immunol       Date:  2006-09-09       Impact factor: 8.317

3.  Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge.

Authors:  Waleed Mustafa; Fetweh H Al-Saleem; Zidoon Nasser; Rebecca M Olson; Jeffrey A Mattis; Lance L Simpson; Matthias J Schnell
Journal:  Vaccine       Date:  2011-05-05       Impact factor: 3.641

4.  Long-term immunity and the effect of one or two booster doses with a lyophilized human rabies vaccine (human diploid cells) at 10 years post primary vaccination in China.

Authors:  Jialei Hu; Shiyuan Wang; Rong Zhou; Hui Liu; Xiaohong Gan; Mingwei Wei; Fengcai Zhu; Fanyue Meng; Wenli Hou
Journal:  Hum Vaccin Immunother       Date:  2021-05-04       Impact factor: 3.452

5.  Rabies virus glycoprotein as a carrier for anthrax protective antigen.

Authors:  Mary Ellen Smith; Martin Koser; Sa Xiao; Catherine Siler; James P McGettigan; Catherine Calkins; Roger J Pomerantz; Bernhard Dietzschold; Matthias J Schnell
Journal:  Virology       Date:  2006-07-03       Impact factor: 3.616

6.  Cellular immune response following pre-exposure and postexposure rabies vaccination by intradermal and intramuscular routes.

Authors:  Manjunatha Muniswamappa Venkataswamy; Shampur Narayan Madhusudana; Sampada Sudarshan Sanyal; Shaheen Taj; Ashwin Yajaman Belludi; Reeta Subramaniam Mani; Nandita Hazra
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

7.  Achieving population-level immunity to rabies in free-roaming dogs in Africa and Asia.

Authors:  Michelle K Morters; Trevelyan J McKinley; Daniel L Horton; Sarah Cleaveland; Johan P Schoeman; Olivier Restif; Helen R Whay; Amelia Goddard; Anthony R Fooks; I Made Damriyasa; James L N Wood
Journal:  PLoS Negl Trop Dis       Date:  2014-11-13

Review 8.  The Cellular Immune Response to Rabies Vaccination: A Systematic Review.

Authors:  Lisanne A Overduin; Jacques J M van Dongen; Leonardus G Visser
Journal:  Vaccines (Basel)       Date:  2019-09-11

9.  Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man.

Authors:  D M C Brinkman; C M Jol-van der Zijde; M M ten Dam; J M Vossen; A D M E Osterhaus; F P Kroon; M J D van Tol
Journal:  J Clin Immunol       Date:  2003-11       Impact factor: 8.542

10.  Outer membrane proteins of Salmonella typhimurium as an adjuvant in rabies vaccine.

Authors:  Iman Ibrahim Negm; Yasser M Ragab; Aly Fahmy Mohamed
Journal:  Clin Exp Vaccine Res       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.